万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 英文名:
3-((4-(2-((3-Chlorophenyl)amino)pyrimidin-4-yl)pyridin-2-yl)amino)propan-1-ol
- 供应商:
上海安毕达生物科技有限公司
- CAS号:
164658-13-3
- 规格:
50μL/1mL/1mg/5mg/10mg/25mg/50mg/100mg
| 规格: | 50μL | 产品价格: | ¥129.0 |
|---|---|---|---|
| 规格: | 1mL | 产品价格: | ¥603.0 |
| 规格: | 1mg | 产品价格: | ¥252.0 |
| 规格: | 5mg | 产品价格: | ¥595.0 |
| 规格: | 10mg | 产品价格: | ¥889.0 |
| 规格: | 25mg | 产品价格: | ¥1491.0 |
| 规格: | 50mg | 产品价格: | ¥2065.0 |
| 规格: | 100mg | 产品价格: | ¥2891.0 |
The protein kinase C (PKC) family is a group of cytosolic serine/threonine kinases that play crucial roles in cell proliferation, differentiation, and cellular signal transductions. The cyclin dependent kinases (CDK) are a family of enzymes involved in cell cycle regulation and oncogenesis. CGP-60474 is a disubstituted pyrimidine-pyridine that inhibits both PKC and CDK3. It inhibits CDK1/cyclinB, CDK2/cyclinA, CDK2/cyclinE, PKC-α, and v-Abl with IC50 values of 17, 80, 50, 250, and 400 nM, respectively. The anti-proliferative effect of CGP-60474 was observed in a panel of tumor cell lines, including colon cancer cells (DLD-1, HTC-15, HTC-116, Colo 205), breast cancer cells (MDA-MB-453, MDA-MB-231, MDA-MB-468, BT-20, ZR-75-1, MCF-7), lung cancer cells (A549, NCI-H596), prostate cancer cells (DU-145, PC-3), ovary cancer cells (PA-1, SW-626, ES-2) with IC50 values ranging from 17 - 280 nM. The treatment of osteosarcoma cell lines U2OS and U2OS/Tag with increasing doses of CGP60474 resulted in a time-dependent growth arrest with IC50 values of 95 and 115 nM, respectively. In normal human fibroblast cell line WI-38, CGP60474 treatment also inhibited the phosphorylation of pRB, a known downstream target of CDK24.
溶解方案(细胞实验)
DMSO 中的溶解度 : ≥ 50 mg/mL (140.52 mM; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)|* "≥" means soluble, but saturation unknown.
溶解方案(动物实验)
"方案 一": "请依序添加每种溶剂:10% DMSO 40% PEG300 5% Tween-80 45% SalineSolubility: ≥ 2.5 mg/mL (7.03 mM); 澄清溶液 此方案可获得 ≥ 2.5 mg/mL(饱和度未知)的澄清溶液。以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;再向上述体系中加入 50 μL Tween-80,混合均匀;然后再继续加入 450 μL 生理盐水 定容至 1 mL。生理盐水的配制:将 0.9 g 氯化钠,溶解于 ddH₂O 并定容至 100 mL,可以得到澄清透明的生理盐水溶液。"
"方案 二": "请依序添加每种溶剂:10% DMSO 90% Corn OilSolubility: ≥ 2.5 mg/mL (7.03 mM); 澄清溶液 此方案可获得 ≥ 2.5 mg/mL(饱和度未知)的澄清溶液,此方案实验周期在半个月以上的动物实验酌情使用。以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。"
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Stanetty P, Hattinger G, et al. Novel and efficient access to phenylamino-pyrimidine type protein kinase C inhibitors utilizing a Negishi cross-coupling strategy. J Org Chem. 2005 Jun 24;70(13):5215-20.
Kuo GH, Deangelis A, Emanuel S, et al. Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitors. J Med Chem. 2005;48(14):4535‐4546. doi:10.1021/jm040214h
Ruetz S, Fabbro D, Zimmermann J, Meyer T, Gray N. Chemical and biological profile of dual Cdk1 and Cdk2 inhibitors. Curr Med Chem Anticancer Agents. 2003;3(1):1‐14. doi:10.2174/1568011033353605
Kuo GH, Deangelis A, Emanuel S, et al. Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitors. J Med Chem. 2005;48(14):4535‐4546. doi:10.1021/jm040214h
Cytokine Gene Polymorphisms: Methods of Detection and Biological Significance
. An important aspect of CGP analyses is the correct interpretation of results particularly determination of their multilocus haplotypes.
被普遍采用,并且定性的性质使得结果的解释难以细化。另一种方法是检测肿瘤基因组中的新抗原;然而,这依赖于整个外显子组和转录组测序,这可能是非常昂贵和耗时的。TMB的测定为新抗原检测提供了一种替代方法,使用突变率本身作为新抗原负担的代理。全面的基因组分析TMB已经被证明可以预测免疫治疗的反应,当使用整个外显子组测序,基因组的所有编码区域(约20,000个基因)的测序。在这项研究中,我们测试了TMB是否可以通过315个基因的靶向综合基因组谱(CGP)来精确测量。我们发现CGP的测定与整个外显子组的测定高度
制剂所诱导的耐药与Bcl-X、表达有关,提示该基因是发生耐药的关键。由此可见,在实施“诱导肿瘤细胞凋亡”这一策略时,既要诱导促凋亡因子表达,又要避免或阻断抗凋亡反应的发生。 可喜的是,当前诱导凋亡的研究已经摆脱了放疗和化疗的局限性而进入基因调控水平。CGP57148B是ABL蛋白的ATP竞争性抑制剂,对慢性骨髓性淋巴瘤(chronic myelogenous leukemias,CML)有促凋亡作用。Bcl-2、c-raf-1和PKC-α的反义核酸对淋巴瘤、黑色素瘤及其他肿瘤有抑瘤
技术资料暂无技术资料 索取技术资料











